Showing results (791-800 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|August 4, 2018
Blood glucose meters and test strips: global market and challenges to access in low-resource settingsEmma Louise Klatman, Alicia Josephine Jenkins, Muhammad Yakoob Ahmedani, et al.
The Lancet. Diabetes & Endocrinology|May 30, 2018
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trialMartin Schlumberger, Sophie Leboulleux, Bogdan Catargi, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2016
Clinical relevance of the bile acid receptor TGR5 in metabolismF Samuel van Nierop, Matthijs J Scheltema, Hannah M Eggink, et al.
The Lancet. Diabetes & Endocrinology|June 19, 2018
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trialKatherine R Tuttle, Mark C Lakshmanan, Brian Rayner, et al.
The Lancet. Diabetes & Endocrinology|June 14, 2019
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trialOfri Mosenzon, Thalia Marie Blicher, Signe Rosenlund, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2019
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome StudyQiuhong Gong, Ping Zhang, Jinping Wang, et al.
The Lancet. Diabetes & Endocrinology|April 21, 2019
Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trialRamon Estruch, Miguel Angel Martínez-González, Dolores Corella, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2022
Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort studyMika Kivimäki, Timo Strandberg, Jaana Pentti, et al.
The Lancet. Diabetes & Endocrinology|January 31, 2021
Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort studyHelen R Murphy, Carla Howgate, Jackie O'Keefe, et al.
The Lancet. Diabetes & Endocrinology|September 22, 2019
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trialIldiko Lingvay, Andrei-Mircea Catarig, Juan P Frias, et al.
Pageof 93